ストックスクリーナーアプリを入手
7.06
8.19%
-0.63
プレマーケット:
7.08
0.02
+0.28%
Organon Co (OGN) 最新ニュース
LSV Asset Management Has $83.67 Million Holdings in Organon & Co. $OGN - MarketBeat
Organon & Co. Q4 Earnings Call Highlights - MarketBeat
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - The Globe and Mail
Organon & Co To Go Ex-Dividend On February 23rd, 2026 With 0.02 USD Dividend Per Share - 富途牛牛
Organon Earnings Call Balances Stability With Rising Risks - TipRanks
Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - simplywall.st
Organon Co earnings missed by $0.13, revenue fell short of estimates - Investing.com UK
Organon Shares Slide on Quarterly Loss and Cautious Outlook - AD HOC NEWS
Organon (OGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Organon & Co. (NYSE:OGN) Announces Quarterly Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat
Organon: Overview of Fourth Quarter Financial Results - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Organon Q4 Earnings ReviewPoor Results Trigger Predictable Sell-Off (NYSE:OGN) - Seeking Alpha
Organon sees FY26 revenue $6.2B, consensus $6.11B - TipRanks
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
Organon reports Q4 adjusted EPS 63c, consensus 73c - TipRanks
Organon Shares Fall After 4Q Earnings Miss Expectations - 富途牛牛
Organon & Co. (NYSE:OGN) Shares Gap Down Following Weak Earnings - MarketBeat
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
OGN: 2025 results show stable revenue and EBITDA, with 2026 guidance flat amid margin and policy headwinds - TradingView
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss By Investing.com - Investing.com India
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com
Organon Co earnings missed by $0.13, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Organon Q4 2025 reveals EPS miss, stock drops 10.8% - Investing.com
Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Organon falls as women’s health unit drives Q4 miss (OGN:NYSE) - Seeking Alpha
Organon: Q4 Earnings Snapshot - kare11.com
Organon Q4 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Issued - 富途牛牛
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill
(OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Revenue $1.51B, vs. FactSet Est of $1.54B - marketscreener.com
Organon shares fall over 5% as Q4 earnings miss expectations By Investing.com - Investing.com South Africa
Press Release: Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - 富途牛牛
Organon earnings: What to look for from OGN - MSN
Organon Q4 Earnings Preview: Cautious view amid weak year (OGN:NYSE) - Seeking Alpha
Earnings Preview: Organon - Benzinga
Organon & Co. (OGN) Stock Analysis: Exploring A Potential 18.3% Upside In Healthcare - DirectorsTalk Interviews
Organon Earnings: What To Look For From OGN - The Globe and Mail
Organon Q4 Earnings Preview: Revenue Decline Projected Amid Sector VolatilityNews and Statistics - IndexBox
Aug Gainers: Does Organon Co meet Warren Buffetts criteria2025 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn
Organon & Co. (NYSE:OGN) Stock Price Down 5.2%Here's What Happened - MarketBeat
Down 72% In 3 Years, Can Organon Stock Finally Recover In 2026? - TIKR.com
Organon & Co (OGN.US) will release its earnings report before the market opens on February 12. - 富途牛牛
Contraceptive Pills Market Is Going to Boom | Pfizer Inc • Bayer AG • Organon & Co - openPR.com
FDA expands use of Organon’s contraception implant up to 5 years - MSN
Organon & Co. (NYSE:OGN) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Organon Launches Third Edition of Women's Health Accelerator Program Across Middle East, Turkey & Africa - The Malaysian Reserve
Organon & Co. (OGN) Projected to Post Earnings on Thursday - MarketBeat
Organon Completes Divesture of JADA System to Laborie Medical - MSN
How Organon & Co. (OGN) Affects Rotational Strategy Timing - Stock Traders Daily
Organon & Co: Can This Beaten-Down Women’s Health Specialist Finally Turn a Corner? - AD HOC NEWS
Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Organon’s Upcoming Report: A Crucial Test for Its Refocused Strategy - AD HOC NEWS
Is It Time To Reassess Organon (OGN) After Its Sharp Multi Year Share Price Slide - Yahoo Finance
Sun Pharma: Disciplined M&A Amid Organon Speculation - Whalesbook
Trend Recap: Is Organon Co subject to activist investor interest2025 Dividend Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Organon and Henlius get FDA nod for Amgen biosimilars - MSN
0.94%
0.39%
大文字化:
|
ボリューム (24 時間):